Acta Neuropharmacologica ›› 2017, Vol. 7 ›› Issue (3): 6-11.DOI: 10.3969/j.issn.2095-1396.2017.03.002

Previous Articles     Next Articles

Advance of Functional Magnetic Resonance Imaging of Brain in Alzheimer’s Disease

BAI Yan-chang1,2,JIA Yan-li2,SONG Ya-xue1,WANG Jian-hua1,2   

  1. 1. Graduate School of Hebei North University,Zhangjiakou,075000,China
    2. The Department of Neurology,Hebei General Hospital,Shijiazhuang,050051,China
  • Online:2017-06-26 Published:2017-12-01
  • Contact: 王建华,男,博士,博士生导师;研究方向:阿尔茨海默病;E-mail:wangjh6304@sina.com
  • About author:白彦昌,男,硕士研究生;研究方向:阿尔茨海默病;E-mail:15833312690@163.com

Abstract: Alzheimer’s disease (AD) is a commom neurodegenerative disorder in the elderly, which mainly manifeste cognitive function, behavioral and psychological symptoms,and activities of daily living. Structue imaging technology is mainly used for measuring the brain structure, which provides support for the diagnosis of AD, but structural imaging of early stage Alzheimer’s disease has no characteristic changes, and it has low sensitivity and specificity for AD diagnosis. However, functional magnetic resonance imaging (fMRI) of brain can compensate for structural imaging technology, and explore the mechanism of pathophysiological of AD. In this paper, we reviewed the functional imaging methods for studying AD nowdays, such as, blood oxygen level dependent functional magnetic resonance imaging (BOLD-fMRI)and diffusion-weighted imaging (DWI), diffusion tensor imaging (DTI), magnetic resonance spectroscopy( MRS) and resting state fMRI( RS-fMRI), and so on.

Key words: Alzheimer&rsquo, s disease(AD), magnetic resonance imaging, structural imaging, functional imaging

CLC Number: